|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400081447 |
|
最近更新日期: Date of Last Refreshed on: |
2024-03-01 09:39:45 |
|
注册时间: Date of Registration: |
2024-03-01 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
经皮穴位电刺激预防骨科老年患者全麻术后谵妄的临床研究 |
|
Public title: |
Clinical study on prevention of delirium after general anesthesia in elderly orthopedic patients with transcutanclus electrical acupoint stimulation |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
经皮穴位电刺激预防骨科老年患者全麻术后谵妄的临床研究 |
|
Scientific title: |
Clinical study on prevention of delirium after general anesthesia in elderly orthopedic patients with transcutanclus electrical acupoint stimulation |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
张志军 |
研究负责人: |
徐惠青 |
|
Applicant: |
Zhang Zhijun |
Study leader: |
Xu Huiqing |
|
申请注册联系人电话: Applicant telephone: |
+86 138 1169 5004 |
研究负责人电话: Study leader's telephone: |
+86 136 8339 5622 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
zh_zhijun@126.com |
研究负责人电子邮件: Study leader's E-mail: |
zh_zhijun@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市朝阳区中环南路6号 |
研究负责人通讯地址: |
北京市朝阳区中环南路6号 |
|
Applicant address: |
6 Zhonghuan South Road, Chaoyang, Beijing |
Study leader's address: |
6 Zhonghuan South Road, Chaoyang, Beijing |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
中国中医科学院望京医院 |
||
|
Applicant's institution: |
Wangjing Hospital, China Academy of Chinese Medical Sciences |
||
|
研究负责人所在单位: |
中国中医科学院望京医院 |
||
|
Affiliation of the Leader: |
Wangjing Hospital, China Academy of Chinese Medical Sciences |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
WJEC-KT-2023-049-P002 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中国中医科学院望京医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Wangjing Hospital, China Academy of Chinese Medical Sciences |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-01-15 00:00:00 |
||
|
伦理委员会联系人: |
李浩 |
||
|
Contact Name of the ethic committee: |
Li Hao |
||
|
伦理委员会联系地址: |
北京市朝阳区中环南路6号 |
||
|
Contact Address of the ethic committee: |
6 Zhonghuan South Road, Chaoyang, Beijing |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 10 8473 9681 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
中国中医科学院望京医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Wangjing Hospital, China Academy of Chinese Medical Sciences |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市朝阳区中环南路6号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
6 Zhonghuan South Road, Chaoyang, Beijing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
中国中医科学院望京医院高水平中医医院建设项目“中医药临床循证研究专项” |
||||||||||||||||||||||
|
Source(s) of funding: |
High-level TCM Hospital Construction Project of Wangjing Hospital, China Academy of Chinese Medical Sciences''TCM Clinical Evidence-based Research Special Project'' |
||||||||||||||||||||||
|
Target disease: |
Delirium after general anesthesia |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
评价经皮穴位电刺激预防老年患者全麻术后谵妄临床研究 |
||||||||||||||||||||||
|
Objectives of Study: |
To evaluate the clinical study on prevention of delirium after general anesthesia in elderly patients with transcutanclus electrical acupoint stimulation |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.年龄均≥65岁; 2.择期行腰椎椎板减压髓核摘除内固定术,手术时长预估≥2h; 3.受试者自愿并签署知情同意书; 4.选择的患者对研究意义有正确认知,对研究人员的观察和评价有良好的依从性强的患者。 |
||||||||||||||||||||||
|
Inclusion criteria |
1.Age ≥65 years; 2.Selected lumbar laminectomy nucleus pulposus internal fixation, the estimated duration of operation ≥2h; 3. Subjects voluntarily sign informed consent; 4.The selected patients should have a correct understanding of the significance of the study and have good compliance with the observation and evaluation of the researchers. |
||||||||||||||||||||||
|
排除标准: |
1.术前体温≥38℃; 2.术前已知或怀疑存在感染; 3.术前存在精神分裂症、癫痫、帕金森综合征、重症肌无力,或谵妄; 4. 因昏迷、严重痴呆或语言障碍而无法交流; 5. BMI大于30 kg/m2; 6. 严重视力或听力障碍无法与心理医师有效交流者; 7. 严重心脑血管疾病患者; 8. 其他各类不适宜行腰椎板切除,髓核摘除内固定术的患者; 9. 拒绝参加本研究; 10. 对针灸有禁忌症(如局部皮肤感染、血小板≤20×109/L等); 11. 因躁动而无法配合治疗; 12. 其他研究者认为不适合参加的情况; |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Preoperative temperature ≥38℃; 2. Known or suspected infection before surgery; 3. Preoperative presence of schizophrenia, epilepsy, Parkinson's syndrome, myasthenia gravis, or delirium; 4. Inability to communicate due to coma, severe dementia or speech impairment; 5. BMI greater than 30 kg/m2; 6. Persons with severe visual or hearing impairment who cannot communicate effectively with psychologists; 7. Patients with severe cardiovascular and cerebrovascular diseases; 8. Other types of patients not suitable for lumbar laminectomy, nucleus pulposus removal internal fixation; 9. Refused to participate in the study; 10. There are contraindications to acupuncture (such as local skin infection, platelet ≤20×109/L, etc.); 11. Unable to cooperate with treatment due to agitation; 12. Situations where participation is not considered appropriate by other researchers; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-01-15 00:00:00至 To 2025-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2024-03-04 00:00:00 至 To 2025-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
采用网络随机系统分组,实施单盲、随机对照研究。患者签署知情同意书后,由网络随机系统随机分组后,告知一位不参与本项研究的协调员,该协调员通知行经皮穴位电刺激治疗师该患者的分组情况:试验组(常规麻醉+TEAS组)、对照组(常规麻醉+假TEAS组) |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
A single blind, randomized controlled study was conducted using a network randomized system. After signing the informed consent, the patients were randomly grouped by the network randomization system, and then informed a coordinator who was not involved in the study, and the coordinator informed the therapist who performed percutaneous acupoint electrical stimulation of the patients' groups: experimental group (conventional anesthesia +TEAS group) and control group (conventional anesthesia + false TEAS group). |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
采用网络随机系统分组,实施单盲、随机对照研究。患者签署知情同意书后,由网络随机系统随机分组后,告知一位不参与本项研究的协调员,该协调员通知行经皮穴位电刺激治疗师该患者的分组情况:试验组(常规麻醉+TEAS组)、对照组(常规麻醉+假TEAS组)。临床观察及评估:采用盲法设计。主麻醉医师、手术医师及负责术前、术后评估的研究者均不知其分组,也不得与其他研究员和患者交流其治疗情况。 |
|
Blinding: |
A single blind, randomized controlled study was conducted using a network randomized system. After signing the informed consent form, the patients were randomly grouped by the network randomization system and informed a coordinator who was not involved in the study, and the coordinator informed the therapist who performed percutaneous acupoint electrical stimulation of the patient's group: trial group (conventional anesthesia +TEAS group) and control group (conventional anesthesia + false TEAS group). Clinical observation and evaluation: Blind design was used. The primary anesthesiologist, the surgeon, and the investigators responsible for pre - and post-operative evaluation were not aware of the group and were not allowed to communicate their treatment status with other researchers and patients. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
试验完成后可进行数据公开:2026年12月 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
The data can be disclosed after the completion of the trial: December 2026 |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据采集采用CRF表,数据管理及统计分析有第三方公司完成 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data collection adopts CRF table, and data management and statistical analysis are completed by a third-party company |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |